Low-dimensional compounds containing bioactive ligands. Part XIII: Square planar anti-cancer Pd(II) complexes with halogenderivatives of 8-quinolinol and dimethylamine

[1]  V. Prachayasittikul,et al.  Discovery of novel halogenated 8‐hydroxyquinoline‐based anti‐MRSA agents: In vitro and QSAR studies , 2020, Drug development research.

[2]  Qi-Pin Qin,et al.  Synthesis of two platinum(II) complexes with 2-methyl-8-quinolinol derivatives as ligands and study of their antitumor activities. , 2019, European journal of medicinal chemistry.

[3]  T. Kanjevac,et al.  Newly Synthesized Heteronuclear Ruthenium(II)/Ferrocene Complexes Suppress the Growth of Mammary Carcinoma in 4T1-Treated BALB/c Mice by Promoting Activation of Antitumor Immunity , 2018, Organometallics.

[4]  D. Milardi,et al.  Amino- and chloro-8-hydroxyquinolines and their copper complexes as proteasome inhibitors and antiproliferative agents. , 2017, Metallomics : integrated biometal science.

[5]  A. Arsenijević,et al.  Low-dimensional compounds containing bioactive ligands. Part IX: Synthesis, structures, spectra, in vitro antimicrobial and anti-tumor activities and DNA binding of Pd(II) complexes with 7-bromo-quinolin-8-ol , 2017 .

[6]  Mustapha Mandewale,et al.  A review on quinoline hydrazone derivatives as a new class of potent antitubercular and anticancer agents , 2017 .

[7]  J. Imrich,et al.  Low-dimensional compounds containing bioactive ligands. Part VIII: DNA interaction, antimicrobial and antitumor activities of ionic 5,7-dihalo-8-quinolinolato palladium(II) complexes with K+ and Cs+ cations. , 2017, Journal of inorganic biochemistry.

[8]  Qi-Pin Qin,et al.  Evaluation of the effect of iodine substitution of 8-hydroxyquinoline on its platinum(II) complex: cytotoxicity, cell apoptosis and telomerase inhibition , 2016 .

[9]  You-nian Liu,et al.  Synthesis, characterization and biological evaluation of a cobalt(II) complex with 5-chloro-8-hydroxyquinoline as anticancer agent , 2016 .

[10]  M. Formica,et al.  New trends in platinum and palladium complexes as antineoplastic agents , 2016 .

[11]  L. Messori,et al.  Gold(III) complexes with hydroxyquinoline, aminoquinoline and quinoline ligands: Synthesis, cytotoxicity, DNA and protein binding studies. , 2015, Journal of inorganic biochemistry.

[12]  Hannah U. Holtkamp,et al.  Impact of the Halogen Substitution Pattern on the Biological Activity of Organoruthenium 8-Hydroxyquinoline Anticancer Agents , 2015 .

[13]  Ž. Bugarčić,et al.  Kinetics, mechanism and equilibrium studies on the substitution reactions of Pd(II) in reference to Pt(II) complexes with bio-molecules , 2015 .

[14]  Joanna Izabela Lachowicz,et al.  Noble metals in medicine: Latest advances , 2015 .

[15]  G. Sheldrick.  SHELXT – Integrated space-group and crystal-structure determination , 2015, Acta crystallographica. Section A, Foundations and advances.

[16]  A. Kapdi,et al.  Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes. , 2014, Chemical Society reviews.

[17]  I. Mlinarič-Raščan,et al.  Structural characterization and biological evaluation of a clioquinol-ruthenium complex with copper-independent antileukaemic activity. , 2014, Dalton transactions.

[18]  Qi-Pin Qin,et al.  Study on potential antitumor mechanism of quinoline-based silver(I) complexes: Synthesis, structural characterization, cytotoxicity, cell cycle and caspase-initiated apoptosis , 2014 .

[19]  J. Pisarčíková,et al.  Low-dimensional compounds containing bioactive ligands. V: Synthesis and characterization of novel anticancer Pd(II) ionic compounds with quinolin-8-ol halogen derivatives. , 2014, Journal of inorganic biochemistry.

[20]  Yan-Cheng Liu,et al.  The antitumor activity of zinc(II) and copper(II) complexes with 5,7-dihalo-substituted-8-quinolinoline. , 2013, European journal of medicinal chemistry.

[21]  H. Beraldo,et al.  Investigation on the bioactivities of clioquinol and its bismuth(III) and platinum(II, IV) complexes , 2013 .

[22]  A. Casini,et al.  Emerging protein targets for metal-based pharmaceutical agents: an update , 2013 .

[23]  J. Padrón,et al.  Novel clioquinol and its analogous platinum complexes: importance, role of the halogen substitution and the hydroxyl group of the ligand. , 2013, Dalton transactions.

[24]  I. Potočňák,et al.  Low-dimensional compounds containing bioactive ligands. Part III: Palladium(II) complexes with halogenated quinolin-8-ol derivatives , 2013 .

[25]  Hong Liang,et al.  High antitumor activity of 5,7-dihalo-8-quinolinolato tin(IV) complexes. , 2013, European journal of medicinal chemistry.

[26]  M. Tegoni,et al.  Copper-dependent cytotoxicity of 8-hydroxyquinoline derivatives correlates with their hydrophobicity and does not require caspase activation. , 2012, Journal of medicinal chemistry.

[27]  V. Kavecansky,et al.  Low-dimensional compounds containing bioactive ligands. Part II: Palladium(II) and platinum(II) complexes with clioquinol as carboplatin analogues , 2012 .

[28]  Dae-Ok Kim,et al.  Comparison of ABTS/DPPH assays to measure antioxidant capacity in popular antioxidant-rich US foods , 2011 .

[29]  Hong Liang,et al.  High cytotoxicity of dihalo-substituted 8-quinolinolato-lanthanides. , 2011, Dalton transactions.

[30]  A. V. Adhikari,et al.  Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1,2,4-triazole moiety. , 2009, European journal of medicinal chemistry.

[31]  Ning Li,et al.  Synthesis and characterization of a mixed-valence hexadecavanadate cluster with half-open framework , 2009 .

[32]  Anthony L. Spek,et al.  Structure validation in chemical crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.

[33]  T. Prescott,et al.  Lunacridine from Lunasia amara is a DNA intercalating topoisomerase II inhibitor. , 2007, Journal of ethnopharmacology.

[34]  J. Pagés,et al.  Quinoline derivatives as promising inhibitors of antibiotic efflux pump in multidrug resistant Enterobacter aerogenes isolates. , 2006, Current drug targets.

[35]  J. Leonard,et al.  Synthesis, anticonvulsant and antihypertensive activities of 8-substituted quinoline derivatives. , 2004, Biological & pharmaceutical bulletin.

[36]  Louis J. Farrugia,et al.  WinGX suite for small-molecule single-crystal crystallography , 1999 .

[37]  C. Rice-Evans,et al.  Antioxidant activity applying an improved ABTS radical cation decolorization assay. , 1999, Free radical biology & medicine.

[38]  A. Zilberstein,et al.  A new series of PDGF receptor tyrosine kinase inhibitors: 3-substituted quinoline derivatives. , 1994, Journal of medicinal chemistry.

[39]  L. Strekowski,,et al.  Synthesis and quantitative structure-activity relationship analysis of 2-(aryl or heteroaryl)quinolin-4-amines, a new class of anti-HIV-1 agents. , 1991, Journal of medicinal chemistry.

[40]  M. S. Khan,et al.  Antimalarials. 13. 5-Alkoxy analogues of 4-methylprimaquine. , 1982, Journal of medicinal chemistry.

[41]  N. Arsenijević,et al.  Low-dimensional compounds containing bioactive ligands. Part VI: Synthesis, structures, in vitro DNA binding, antimicrobial and anticancer properties of first row transition metal complexes with 5-chloro-quinolin-8-ol. , 2016, Journal of inorganic biochemistry.

[42]  Hong Liang,et al.  Synthesis, crystal structure, cytotoxicity and DNA interaction of 5,7-dichloro-8-quinolinolato-lanthanides. , 2013, European journal of medicinal chemistry.

[43]  P. Nasveld,et al.  Treatment of acute vivax malaria with tafenoquine. , 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[44]  C. Berset,et al.  Use of a Free Radical Method to Evaluate Antioxidant Activity , 1995 .